Vaidya Sane Ayurved Laboratories Limited (NSE:MADHAVBAUG)
India · Delayed Price · Currency is INR 146.45
-0.05 (-0.03%)
Oct 22, 2026, 1:45 PM IST
NSE:MADHAVBAUG Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 1,541 | 1,753 | 985 | 1,829 | 2,471 | 2,050 | |
Market Cap Growth | -43.02% | 77.92% | -46.15% | -25.96% | 20.51% | - |
Enterprise Value | 1,336 | 1,610 | 802 | 1,662 | 2,277 | 2,054 |
Last Close Price | 146.45 | 166.60 | 93.70 | 174.00 | 235.00 | 194.66 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 18.22 | 19.50 | 13.81 | 92.37 | 51.12 | 59.10 |
PS Ratio | 1.44 | 1.64 | 1.07 | 1.84 | 2.49 | 2.74 |
PB Ratio | 1.76 | 2.01 | 1.58 | 3.29 | 6.11 | 5.71 |
P/TBV Ratio | 2.06 | 2.34 | 1.96 | 3.81 | 6.51 | 5.89 |
P/FCF Ratio | - | - | 5.71 | - | - | - |
P/OCF Ratio | 28.47 | 32.39 | 3.83 | - | 3854.39 | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.25 | 1.51 | 0.88 | 1.67 | 2.30 | 2.75 |
EV/EBITDA Ratio | 8.95 | 10.79 | 5.03 | 36.90 | 28.99 | 29.90 |
EV/EBIT Ratio | 14.38 | 17.33 | 6.72 | 122.06 | 43.31 | 42.63 |
EV/FCF Ratio | - | - | 4.65 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.03 | 0.03 | 0.02 | 0.03 | 0.00 | 0.03 |
Debt / EBITDA Ratio | 0.17 | 0.17 | 0.09 | 0.37 | 0.02 | 0.15 |
Debt / FCF Ratio | - | - | 0.09 | - | - | - |
Net Debt / Equity Ratio | -0.23 | -0.23 | -0.23 | -0.30 | -0.38 | -0.50 |
Net Debt / EBITDA Ratio | -1.37 | -1.37 | -0.89 | -3.70 | -1.96 | -2.64 |
Net Debt / FCF Ratio | 8.30 | 8.30 | -0.82 | 1.34 | 2.23 | 1.11 |
Asset Turnover | 1.17 | 1.17 | 1.23 | 1.59 | 1.86 | 1.93 |
Inventory Turnover | 5.77 | 5.77 | 5.31 | 7.43 | 12.17 | 15.49 |
Quick Ratio | 3.00 | 3.00 | 1.94 | 2.15 | 1.67 | 1.59 |
Current Ratio | 3.99 | 3.99 | 2.56 | 2.70 | 2.16 | 1.91 |
Return on Equity (ROE) | 11.98% | 11.98% | 12.08% | 4.12% | 12.66% | 15.20% |
Return on Assets (ROA) | 6.33% | 6.33% | 10.05% | 1.37% | 6.17% | 7.77% |
Return on Invested Capital (ROIC) | 11.54% | 13.41% | 19.78% | 2.95% | 18.46% | 25.45% |
Return on Capital Employed (ROCE) | 9.90% | 9.90% | 17.80% | 2.30% | 12.50% | 12.90% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 5.49% | 5.13% | 7.24% | 1.08% | 1.96% | 1.69% |
FCF Yield | -1.60% | -1.41% | 17.52% | -6.78% | -2.80% | -7.95% |
Dividend Yield | - | - | - | - | 0.21% | - |
Payout Ratio | - | - | - | - | 5.44% | - |
Buyback Yield / Dilution | 9.38% | 9.38% | -0.00% | -17.37% | - | -50.73% |
Total Shareholder Return | 9.38% | 9.38% | -0.00% | -17.37% | 0.21% | -50.73% |